Related Experiment Video
Updated: Jun 7, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Medial temporal atrophy predicts the limbic comorbidities in lewy body disease
Keita Sakurai1, Daita Kaneda2, Satoru Morimoto3
1Department of Radiology, National Center for Geriatrics and Gerontology, 7-430 Morioka-Cho, Obu, Aichi, 474-8511, Japan. ksak666@yahoo.co.jp.
Purpose:
Although neuropathological comorbidities, including Alzheimer's disease neuropathological change (AD-NC) and limbic-predominant age-related TAR DNA-binding protein 43encephalopathy neuropathological change (LATE-NC), are associated with medial temporal atrophy in patients with Lewy body disease (LBD), the diagnostic performance of magnetic resonance imaging (MRI)-derived indices remains unclear. This study aimed to investigate the diagnostic performance of MRI-derived indices representing medial temporal atrophy in differentiating between LBD with AD-NC and/or LATE-NC (mixed LBD [mLBD]) and without these comorbidities (pure LBD [pLBD]).
Methods:
This study included 24 and 16 patients with pathologically confirmed mLBD and pLBD, respectively. In addition to the well-known medial temporal atrophy and entorhinal cortex atrophy (ERICA) scores, the cross-sectional areas of the bilateral entorhinal cortices/parahippocampal gyri (ABEP) were segmented manually.
Results:
Even incorporating various covariates such as age at MRI examination, sex, argyrophilic grain, the MRI-derived indices, especially ABEP, significantly correlated with the severity of AD-NC, and showed a trend of correlation with LATE-NC. For the differentiation between all mLBD and pLBD, the ERICA score and ABEP demonstrated higher diagnostic performance (area under the receiver-operating-characteristic curve [AUC] of 0.80 and 0.87, respectively). Additionally, the highest diagnostic performance for ABEP (AUC, 0.94; sensitivity, 100%; specificity, 88.9%; accuracy, 96%) was observed in differentiating between pLBD and mLBD with two comorbidities (AD-NC and LATE-NC).
Conclusion:
In patients with pathologically confirmed LBD, medial temporal atrophy was significantly correlated with AD-NC, and showed a trend of correlation with LATE-NC. Moreover, MRI-derived indices indicative of medial temporal atrophy were useful in diagnosing these comorbidities.
Insights
Magnetic resonance imaging (MRI) indices of medial temporal atrophy can help differentiate pure Lewy body disease (LBD) from mixed LBD with Alzheimer's disease neuropathological change (AD-NC) or limbic-predominant age-related TAR DNA-binding protein 43encephalopathy neuropathological change (LATE-NC). These MRI findings correlate with AD-NC severity and aid in diagnosing LBD comorbidities.
Area of Science:
- Neurology
- Radiology
- Pathology
Background:
- Lewy body disease (LBD) often co-occurs with Alzheimer's disease neuropathological change (AD-NC) and limbic-predominant age-related TAR DNA-binding protein 43encephalopathy neuropathological change (LATE-NC).
- Medial temporal atrophy is associated with these comorbidities in LBD, but the diagnostic utility of MRI is not well-established.
Purpose of the Study:
- To evaluate the diagnostic performance of MRI-derived medial temporal atrophy indices in distinguishing between pure LBD and mixed LBD (mLBD) with AD-NC and/or LATE-NC.
Main Methods:
- Included 24 pathologically confirmed mLBD and 16 pure LBD patients.
- Assessed medial temporal atrophy using entorhinal cortex atrophy (ERICA) scores and cross-sectional areas of entorhinal cortices/parahippocampal gyri (ABEP).
Main Results:
- ABEP and ERICA scores showed significant diagnostic performance in differentiating mLBD from pure LBD (AUC 0.87 and 0.80, respectively).
- ABEP demonstrated high diagnostic performance (AUC 0.94) in distinguishing pure LBD from mLBD with both AD-NC and LATE-NC.
- MRI indices, particularly ABEP, correlated with AD-NC severity and showed a trend with LATE-NC.
Conclusions:
- Medial temporal atrophy on MRI is a valuable tool for diagnosing comorbidities in pathologically confirmed LBD.
- MRI-derived indices effectively differentiate LBD subtypes based on the presence of AD-NC and LATE-NC.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Functional Brain Systems: Limbic System
Dementia
The progression of dementia is generally gradual....
Parkinson's Disease: Overview
Neural Regulation

